Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,796 followers.

https://t.co/57xGIN8haf https://t.co/pLFVtN3T1d (2/2) https://t.co/JRuXgvSC2M

07 Nov 2022

Reply Repost Favourite

New Research: Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority https://t.co/EB3j2PvjlX #pharmacology

15 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.